David L. Morse
Researcher
Cancer Imaging and Metabolism
H. Lee Moffitt Cancer Center and Research Institute
United States of America
Biography
David L. Morse is an associate Member at MOFFITT Cancer center his education & training at University of Arizona and he had done PhD on Molecular Cellular Biology and Cancer Biology. Most of his branch of knowledge includes: Cancer Imaging and Metabolism, Melanoma Research Center of Excellence, Lung Cancer Center of Excellence, Cancer Imaging and Technology, Chemical Biology and Molecular Medicine Program.
Research Interest
Dr. Morse’s research projects are focused on the identification and validation of cell-surface markers for cancer, discovery of ligands or antibodies specific for binding validated markers, and the development of targeted molecular imaging probes and nanoagents for the detection and treatment of cancer. The ultimate goal of this work is to translate novel probes into the clinic for use in cancer diagnosis and staging, intraoperative margin detection and the targeted delivery of therapy.
Publications
-
Khabibullin AR, Karolak A, Budzevich MM, Woods LM, Martinez MV, et al.(2016) SU-C-204-03: DFT Calculations of the Stability of DOTA-Based-Radiopharmaceuticals. Med Phys 43:3314.
-
Roy J, Putt KS, Coppola D, Leon ME, Khalil FK, et al.(2016) Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget 7:14605-14615.
-
McFarland C, Yaglom JA, Wojtkowiak JW, Scott J, Morse DL, et al (2017) The Damaging Effect of Passenger Mutations on Cancer Progression. Cancer Res.